α-Glucosidase inhibitory potential of Oroxylum indicum using molecular docking, molecular dynamics, and in vitro evaluation

• Egile Nagusiak: Samhita Bhaumik (Egilea), Alekhya Sarkar (Egilea), Sudhan Debnath (Egilea), Bimal Debnath (Egilea), Rajat Ghosh (Egilea), Magdi E.A. Zaki (Egilea), Sami A. Al-Hussain (Egilea)
• Formatua: Liburua
• Argitaratua: Elsevier, 2024-06-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Background: According to the International Diabetes Federation, there will be 578 million individuals worldwide with diabetes by 2030 and 700 million by 2045. One of the promising drug targets to fight diabetes is α-glucosidase (AG), and its inhibitors may be used to manage diabetes by reducing the...